HFA Premium Access

Telmisartan versus Enalapril in heart failure with reduced ejection fraction patients with moderately impaired kidney functions; randomized controlled trial. (TRIUMF trial)

Congress Presentation

About the speaker

Doctor Salma Abouel Naga

Kasr Al Ainy School of Medicine, Cairo (Egypt)
0 follower

7 more presentations in this session

Survey and interview-based study on readiness of heart failure polypill implementation

Speaker: Doctor R. Bin Raja Shariff (Selangor, MY)


Atrioventricular conduction disorders associated to betablocker treatment in patients with heart failure

Speaker: Doctor D. Marcu (Iasi, RO)


The efficacy of combination therapy of corticosteroids and methotrexate for cardiac sarcoidosis, prolonged analysis

Speaker: Doctor Y. Nishihata (Tokyo, JP)


Transthyretin-directed antisense oligonucleotide therapy effects on ATTRv myocardiopathy

Speaker: Doctor A. Garcia (Lisbon, PT)


Meta-analysis on the role of potassium binders in optimization of guideline-directed medical therapy and safety outcomes in patients with heart failure

Speaker: Doctor I. Tumang (Taguig, PH)


Access the full session

Chronic heart failure - pharmacotherapy 2

Speakers: Doctor S. Abouel Naga, Doctor R. Bin Raja Shariff, Doctor D. Marcu, Doctor Y. Nishihata, Doctor A. Garcia...

About the event


Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

ESC 365 is supported by